News
12-12-2009, 05:02 AM
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) announced results from two collaborative group-sponsored randomized, double-blind, placebo-controlled Phase 2 trials were presented at the 32nd Annual San Antonio Breast Cancer Symposium (SABCS)...
More... (http://www.medicalnewstoday.com/articles/173836.php)
More... (http://www.medicalnewstoday.com/articles/173836.php)